These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 29721353)

  • 1. Immunoexcitotoxicity as the central mechanism of etiopathology and treatment of autism spectrum disorders: A possible role of fluoride and aluminum.
    Strunecka A; Blaylock RL; Patocka J; Strunecky O
    Surg Neurol Int; 2018; 9():74. PubMed ID: 29721353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune-glutamatergic dysfunction as a central mechanism of the autism spectrum disorders.
    Blaylock RL; Strunecka A
    Curr Med Chem; 2009; 16(2):157-70. PubMed ID: 19149568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic Fluoride Exposure and the Risk of Autism Spectrum Disorder.
    Strunecka A; Strunecky O
    Int J Environ Res Public Health; 2019 Sep; 16(18):. PubMed ID: 31527457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A possible central mechanism in autism spectrum disorders, part 1.
    Blaylock RL
    Altern Ther Health Med; 2008; 14(6):46-53. PubMed ID: 19043938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A possible central mechanism in autism spectrum disorders, part 2: immunoexcitotoxicity.
    Blaylock RL
    Altern Ther Health Med; 2009; 15(1):60-7. PubMed ID: 19161050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erratum: Immunoexcitotoxicity as the central mechanism of etiopathology and treatment of autism spectrum disorders: A possible role of fluoride and aluminum.
    Surg Neurol Int; 2018; 9():98. PubMed ID: 29888737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinson's disease: Microglial/macrophage-induced immunoexcitotoxicity as a central mechanism of neurodegeneration.
    Blaylock RL
    Surg Neurol Int; 2017; 8():65. PubMed ID: 28540131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A possible central mechanism in autism spectrum disorders, part 3: the role of excitotoxin food additives and the synergistic effects of other environmental toxins.
    Blaylock RL
    Altern Ther Health Med; 2009; 15(2):56-60. PubMed ID: 19284184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoexcitotoxicity as a central mechanism in chronic traumatic encephalopathy-A unifying hypothesis.
    Blaylock RL; Maroon J
    Surg Neurol Int; 2011; 2():107. PubMed ID: 21886880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Putative Role of Environmental Mercury in the Pathogenesis and Pathophysiology of Autism Spectrum Disorders and Subtypes.
    Morris G; Puri BK; Frye RE; Maes M
    Mol Neurobiol; 2018 Jun; 55(6):4834-4856. PubMed ID: 28733900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on Atypicalities of Central Nervous System in Autism Spectrum Disorder.
    Shuid AN; Jayusman PA; Shuid N; Ismail J; Kamal Nor N; Naina Mohamed I
    Brain Sci; 2020 May; 10(5):. PubMed ID: 32443912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond infection - Maternal immune activation by environmental factors, microglial development, and relevance for autism spectrum disorders.
    Bilbo SD; Block CL; Bolton JL; Hanamsagar R; Tran PK
    Exp Neurol; 2018 Jan; 299(Pt A):241-251. PubMed ID: 28698032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamate mediated signaling in the pathophysiology of autism spectrum disorders.
    Choudhury PR; Lahiri S; Rajamma U
    Pharmacol Biochem Behav; 2012 Feb; 100(4):841-9. PubMed ID: 21756930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Endocannabinoid System as a Window Into Microglial Biology and Its Relationship to Autism.
    Araujo DJ; Tjoa K; Saijo K
    Front Cell Neurosci; 2019; 13():424. PubMed ID: 31619967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microglia as possible therapeutic targets for autism spectrum disorders.
    Andoh M; Ikegaya Y; Koyama R
    Prog Mol Biol Transl Sci; 2019; 167():223-245. PubMed ID: 31601405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental microglial priming in postmortem autism spectrum disorder temporal cortex.
    Lee AS; Azmitia EC; Whitaker-Azmitia PM
    Brain Behav Immun; 2017 May; 62():193-202. PubMed ID: 28159644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiota, Immune System and Autism Spectrum Disorders: An Integrative Model towards Novel Treatment Options.
    Carpita B; Marazziti D; Palego L; Giannaccini G; Betti L; Dell'Osso L
    Curr Med Chem; 2020; 27(31):5119-5136. PubMed ID: 31448708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Glutamatergic Excitotoxicity in Neuromyelitis Optica Spectrum Disorders.
    da Silva APB; Souza DG; Souza DO; Machado DC; Sato DK
    Front Cell Neurosci; 2019; 13():142. PubMed ID: 31031597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglia in the pathogenesis of autism spectrum disorders.
    Koyama R; Ikegaya Y
    Neurosci Res; 2015 Nov; 100():1-5. PubMed ID: 26116891
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.